Our study suggested that BRCA1 and BRCA2 mutations accounted for a considerable proportion of the hereditary breast/ovarian cancer patients in eastern China and that the spectrum of the mutations in these genes exhibited unique features. This evidence concerns the gene BRCA1 and ovarian carcinoma.